ARRY 520 trifluoroacetate
Cat. No. 4676
Alternative Name: Filanesib
Chemical Name: (2S)-2-(3-Aminopropyl)-5-(2,5-diflu
Biological ActivityPotent kinesin spindle protein (KSP) inhibitor (IC50 = 6 nM); selective for KSP over >250 other receptors and kinases at a concentration of 10 μM. Displays robust antitumor activity in bortezomib-resistant xenografts either alone or in combination with bortezomib. Induces degradation of Mcl-1; exhibits comparable cytotoxic activity to taxol (Cat. No. 1097) in epithelial ovarian cancer cells. Active in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Tunquist et al (2010) Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520. Mol.Cancer.Ther. 9 2046. PMID: 20571074.
Kim et al (2009) KSP inhibitor ARRY-520 as a substitute for Paclitaxel in type I ovarian cancer cells. J.Transl.Med. 7 63. PMID: 19619321.
Woessner et al (2009) ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. Anticancer Res. 29 4373. PMID: 20032381.
If you know of a relevant reference for ARRY 520 trifluoroacetate please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ARRY 520 trifluoroacetate from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: ARRY 520 trifluoroacetate, supplier, ARRY520, trifluoroacetate, potent, selective, kinesin, spindle, protein, KSP, inhibitors, inhibits, selective, antitumor, degrades, Mcl-1, Tocris Bioscience, Kinesin Inhibitor products